Michael Barbella, Managing Editor02.17.24
MPO website loyalists exhibited their devotion for diabetes and sleep apnea news this past week.
ResMed's AirCurve 11 series launch topped pageviews, as readers flocked to the site to learn more about the company’s newest bilevel devices that use two levels of support—inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). The AirCurve 11 series is combined with digital tech to help treat sleep apnea and features both cellular and Bluetooth communication as well as a heated humidifier that can be controlled via a Climate Control feature or manually set. Over-the-Air updates deliver software and new digital features to the device.
Diabetes-related dispatches were second-best this week, powered by a product launch from Tandem Diabetes Care, and an in-depth interview with Phillips-Medisize about innovation in diabetes treatment devices. The latter discussion explored the impact of greater connectivity on treatment, the popularity of continuous glucose monitors, and the sector's future prospects. Tandem Diabetes Care, meanwhile, drove traffic by unveiling its new Tandem Mobi automated insulin delivery (AID) system in the United States. Less than half the size of the company’s t:slim X2 insulin pump, Tandem Mobi features the company’s Control-IQ technology, a hybrid closed-loop AID feature. Control-IQ predicts and helps prevent high and low blood sugar, and has shown improved time in range throughout the day and night in clinical trials and real-world studies, according to the company.
Other digital items of interest this past week included Norwood Medical's new CEO, and Trelleborg's acquisition of advanced precision silicone components manufacturer Baron Group.
ResMed's AirCurve 11 series launch topped pageviews, as readers flocked to the site to learn more about the company’s newest bilevel devices that use two levels of support—inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). The AirCurve 11 series is combined with digital tech to help treat sleep apnea and features both cellular and Bluetooth communication as well as a heated humidifier that can be controlled via a Climate Control feature or manually set. Over-the-Air updates deliver software and new digital features to the device.
Diabetes-related dispatches were second-best this week, powered by a product launch from Tandem Diabetes Care, and an in-depth interview with Phillips-Medisize about innovation in diabetes treatment devices. The latter discussion explored the impact of greater connectivity on treatment, the popularity of continuous glucose monitors, and the sector's future prospects. Tandem Diabetes Care, meanwhile, drove traffic by unveiling its new Tandem Mobi automated insulin delivery (AID) system in the United States. Less than half the size of the company’s t:slim X2 insulin pump, Tandem Mobi features the company’s Control-IQ technology, a hybrid closed-loop AID feature. Control-IQ predicts and helps prevent high and low blood sugar, and has shown improved time in range throughout the day and night in clinical trials and real-world studies, according to the company.
Other digital items of interest this past week included Norwood Medical's new CEO, and Trelleborg's acquisition of advanced precision silicone components manufacturer Baron Group.